Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GeneNews, a Canada-based molecular diagnostics company, has reported that it will undertake a two-year joint project to develop blood-based diagnostic tests for liver cancer, hepatitis B and nasopharyngeal cancer based on its Sentinel Principle platform technology.
Subscribe to our email newsletter
The Malaysian Ministry of Health will provide a grant of MYR5 million to support this work which will be executed by GeneNews (Malaysia) Sdn Bhd, a subsidiary of GeneNews.
CC Liew, co-founder and chief scientist of GeneNews, said: “Our project with the Malaysian Ministry of Health aims to develop blood-based, genomic diagnostic tests for the early detection and staging of these three diseases.
“This collaboration also gives GeneNews the opportunity to train select Malaysian Ministry of Health staff, contributing to their human capital development, and also adding depth to GeneNews’s R&D expertise in Malaysia.”